Version history

{
  "session_id": "sess_SDA-2026-04-13-gap-pubmed-20260410-142329-c1db787b_20260413-221849",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "critique",
  "content": "\n\n# Critical Evaluation of Hypotheses on B Cell Tolerance to AQP4\n\n---\n\n## Hypothesis 1: Receptor Editing via RAG-Mediated V(D)J Recombination\n\n### Strongest Specific Weakness: Anatomical Paradox of Central Tolerance\n\nThe hypothesis invokes central tolerance mechanisms (bone marrow receptor editing) without addressing a fundamental prerequisite: *how do developing B cells in the bone marrow encounter the AQP4 autoantigen?* AQP4 is predominantly expressed in the central nervous system—specifically in astrocytic foot processes at the blood-brain barrier, optic nerves, and spinal cord (PMID: 12401984). There is no established mechanism for CNS antigens to access the bone marrow microenvironment at sufficient concentrations to tolerize developing B cells. This is not a peripheral antigen like DNA or insulin with known splenic or thymic cross-presentation; AQP4 is anatomically sequestered.\n\nCentral tolerance requires cognate antigen recognition in the bone marrow. Without AQP4 presence or transport there, receptor editing of AQP4-specific B cells cannot occur in situ. An alternative model—peripheral tolerance of naïve AQP4-specific B cells—must explain the observed tolerance state.\n\n### Counter-Evidence and Complications\n\n1. **RAG re-expression in mature/immature B cells is not well-established**: While receptor editing occurs in ~25% of autoreactive specificities (as cited), this primarily occurs at the pre-B cell stage during normal development. The assertion that *already-formed* immature B cells with AQP4-reactivity can reactivate RAG1/2 for secondary V(D)J",
  "tokens_used": "395"
}